Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > News > Northwestern fetches $700 million for drug

December 19th, 2007

Northwestern fetches $700 million for drug

NU sold the rights to Royalty Pharma, a New York-based firm with a history of buying royalty rights from research universities.

Northwestern has been using some of its Lyrica royalties bonanza to fund its drive to become the nation's top nanotechnology research center. The university has vowed to hire more scientific superstars in the coming year, relying on the prestige of its nanotech team and cash from royalty payments to attract more talent.


Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


SUNY Poly Welcomes DPS as the Global Engineering Firm Opens Its U.S. Advanced Technology Group Headquarters at Cutting-Edge ZEN Building November 20th, 2015

Pioneering research boosts graphene revolution November 17th, 2015

University of Leeds Expands Structural Biology with Purchase of Multiple Titan Krios TEMs from FEI November 10th, 2015

Iran Signs MoU to Export Nanodevices to China November 9th, 2015


A new form of real gold, almost as light as air November 27th, 2015

Medical and aerospace electronics powered by Picosun ALD November 26th, 2015

MIT mathematicians identify limits to heat flow at the nanoscale: New formula identifies limits to nanoscale heat transfer, may help optimize devices that convert heat to electricity November 25th, 2015

Physicists explain the unusual behavior of strongly disordered superconductors: Using a theory they developed previously, the scientists have linked superconducting carrier density with the quantum properties of a substance November 25th, 2015

Patents/IP/Tech Transfer/Licensing

Electric fields remove nanoparticles from blood with ease November 24th, 2015

Calling All Industries: Get Your Graphene By The Kiloton November 21st, 2015

Nanotech-based sensor developed to measure microRNAs in blood, speed cancer detection November 19th, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA November 16th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic